VISA KORĒJAS KOSMĒTIKA ŠEIT❤️
Mainīt reģionālos iestatījumus
VISA KORĒJAS KOSMĒTIKA ŠEIT❤️

| Revilab ML 03 | Prevent optic nerve atrophy |
| Visoluten №60 | Prevent the development of the retinal degeneration |
| Cerluten №60 | Prevent the development of the retinal degeneration |
| Ventfort №60 | Normalizes the condition of the vascular wall |
| Visoluten №60 | Prevent the development of the retinal degeneration |
| Cerluten №60 | Prevent the development of the retinal degeneration |
| Ventfort №60 | Normalizes the condition of the vascular wall |
| Retisil | Promotes a noticeable improvement in blood circulation and metabolism in the retina |
| Revilab SL 02 | It normalizes vascular permeability; reduces the appearance of local inflammatory reaction; stimulates repair processes in diseases and injuries of the retina. |
| Revilab ML 03 | Prevent optic nerve atrophy |
| Visoluten №60 | Prevent the development of the retinal degeneration |
| Cerluten №60 | Prevent the development of the retinal degeneration |
| Ventfort №60 | Normalizes the condition of the vascular wall |
| Visoluten №60 | Prevent the development of the retinal degeneration |
| Cerluten №60 | Prevent the development of the retinal degeneration |
| Ventfort №60 | Normalizes the condition of the vascular wall |
| Retisil | Promotes a noticeable improvement in blood circulation and metabolism in the retina |
| Revilab SL 02 | It normalizes vascular permeability; reduces the appearance of local inflammatory reaction; stimulates repair processes in diseases and injuries of the retina. |
| Nosaukums | Daudzums | Lietošanas norādījumi | Darbības mehānisms | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||